久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Additional 61,120 vials of Liposomal Amphotericin B allocated to states/UTs and central institutions: Gowda

expresspharmaJune 25, 2021

Tag: Liposomal Amphotericin B , Mucormycosis , DV Sadananda Gowda

The Union Minister for Chemicals and Fertilizers DV Sadananda Gowda 23rd announced that an additional 61,120 vials of Liposomal Amphotericin-B, used in the treatment for mucormycosis, have been allocated to all states/ Union Territories (UTs) and central institutions.

“Additional 61,120 vials of #LiposomalAmphotericinB have been allocated to all states/UTs and central institutions today. So far, approximately 7.9 lakh vials have been allocated across the country, maintaining adequate availability to patients of mucormycosis,” he wrote on Twitter.

Previous:Zydus Cadila receives tentative approval from USFDA for Fingolimod Capsules .25mg

Next:Cipla gets USFDA nod for inhalation product

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service